Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer

Fig. 3

Surface marker profile of EVs isolated from lymphatic drainage fluid obtained from breast cancer patients. EV surface proteins were profiled using multiplex bead-based flow cytometry assay. Captured EVs were counterstained with APC-labeled detection antibodies (mixture of anti-CD9, anti-CD63, and anti-CD81 antibodies). The 24 out of 37 proteins that were found to be positive (MFI > 20) in any of the patients are shown in the figure. Data is presented as CD9/CD63/CD81 normalized background subtracted (isotype control and blank samples) median fluorescence intensity (MFI). Asterisks indicate proteins detected in all patients

Back to article page